Mesoblast (MEOBF) Enterprise Value (2017 - 2025)
Mesoblast (MEOBF) has disclosed Enterprise Value for 9 consecutive years, with -$161.6 million as the latest value for Q2 2025.
- Quarterly Enterprise Value fell 156.59% to -$161.6 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$161.6 million through Jun 2025, down 156.59% year-over-year, with the annual reading at -$161.6 million for FY2025, 156.59% down from the prior year.
- Enterprise Value hit -$161.6 million in Q2 2025 for Mesoblast, down from -$63.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$60.4 million in Q2 2022 to a low of -$161.6 million in Q2 2025.
- Historically, Enterprise Value has averaged -$98.6 million across 5 years, with a median of -$71.3 million in 2023.
- Biggest five-year swings in Enterprise Value: soared 55.84% in 2022 and later crashed 156.59% in 2025.
- Year by year, Enterprise Value stood at -$136.9 million in 2021, then skyrocketed by 55.84% to -$60.4 million in 2022, then decreased by 17.98% to -$71.3 million in 2023, then rose by 11.72% to -$63.0 million in 2024, then plummeted by 156.59% to -$161.6 million in 2025.
- Business Quant data shows Enterprise Value for MEOBF at -$161.6 million in Q2 2025, -$63.0 million in Q2 2024, and -$71.3 million in Q2 2023.